Zydus Lifesciences (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Zydus Lifesciences" in English language version.

refsWebsite

Global rank English rank

7indiatimes.com

17^th place

15^th place

3business-standard.com

350^th place

206^th place

1bseindia.com

4,215^th place

2,383^rd place

1crisil.com

low place

1thehindubusinessline.com

724^th place

431^st place

1mapsofindia.com

3,637^th place

2,559^th place

1fortuneindia.com

9,261^st place

4,974^th place

1forbesindia.com

1,886^th place

990^th place

1bloomberg.com

99^th place

77^th place

1fda.gov

447^th place

338^th place

1edudwar.com

low place

1web.archive.org

1^st place

1hep-c-news.com

low place

1thehindu.com

52^nd place

35^th place

1nytimes.com

7^th place

1reuters.com

49^th place

47^th place

1forbes.com

54^th place

48^th place

1livemint.com

390^th place

227^th place

1worldcat.org

5^th place

bloomberg.com

Company Overview of Química e Farmacêutica Nikkho do Brasil Ltda Bloomberg

bseindia.com

"Earnings Presentation: Q4 and Full Year FY24" (PDF). BSE. Zydus Lifesciences Ltd. Retrieved 29 May 2024.

business-standard.com

Umarji, Vinay (24 February 2022). "Cadila Healthcare changes name to Zydus Lifesciences Limited". Business Standard India. Retrieved 17 March 2022.
"Cadila Healthcare changes name to Zydus Lifesciences Limited". Business Standard. Retrieved 2 October 2023.
Umarji, Vinay (12 June 2020). "Gilead finds fourth partner for manufacture of Remdesivir in Zydus Cadila". Business Standard India.

crisil.com

"Cadila Healthcare Limited". CRISIL. Retrieved 31 January 2023.

edudwar.com

"Know 10 largest Pharmaceutical Companies in India". Edu Dwar. Retrieved 28 July 2023.

fda.gov

"Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance". FDA. 29 September 2020. Retrieved 2 October 2023.

forbes.com

"Pankaj Patel". Forbes. Retrieved 15 June 2020.

forbesindia.com

"India's Richest 2019: Cadila's Patels' Quest For The Magic Pill". Forbes India. Retrieved 2 October 2023.

fortuneindia.com

"Cadila Healthcare - Fortune 500 List 2020 - Fortune India". www.fortuneindia.com. Retrieved 12 January 2021.

hep-c-news.com

"Hepatitis C treatment in India for less than $1000". hep-c-news.com. Hep C News. 11 July 2016. Archived from the original on 16 September 2016.

indiatimes.com

timesofindia.indiatimes.com

"Cadila shares close IPO price after 3 years". The Times of India. 29 July 2003. Retrieved 2 October 2023.
"German Remedies to be merged with Cadilla". The Times of India. 9 August 2003. Retrieved 2 October 2023.
Zydus Cadila Desidustat Gets USFDA Nod To Initiate Clinical Trials On Cancer Patients The Times Of India 23 July 2020

economictimes.indiatimes.com

"Cadila Healthcare Profit and Loss Reports - The Economic Times". economictimes.indiatimes.com. Retrieved 15 June 2020.
Dandekar, Vikas (28 December 2016). "Cadila Healthcare misbranded Saroglitazar, says US FDA". The Economic Times. ISSN 0013-0389. Retrieved 1 August 2023.

articles.economictimes.indiatimes.com

Zydus Cadila launches biosimilar of AbbVie's Humira in India The Economic Times 9 December 2014

health.economictimes.indiatimes.com

"Zydus Cadila begins human clinical trials of COVID-19 vaccine candidate - ET HealthWorld". ETHealthworld.com.

livemint.com

"The dangerous failure to stop tainted remdesivir". mint. 23 December 2021. Retrieved 1 August 2023.

mapsofindia.com

business.mapsofindia.com

"A Complete Overview on Cadila Healthcare, a growing and popular company in India". business.mapsofindia.com. 21 June 2011. Retrieved 4 February 2009.

nytimes.com

"Zydus Cadila's COVID-19 Vaccine Candidate Found Safe in Early-Stage Human Trial". The New York Times. 5 August 2020.

reuters.com

"India gives emergency approval for world's first COVID-19 DNA vaccine". Reuters. 20 August 2021.

thehindu.com

"Potential COVID-19 vaccine by Zydus Cadila gets DCGI nod for human clinical trials". The Hindu. 3 July 2020.

thehindubusinessline.com

"Zydus launches SoviHep - the breakthrough therapy for Hepatitis C in alliance with Gilead Sciences". The Hindu Business Line. 17 March 2015. Retrieved 29 December 2017.

web.archive.org

"Hepatitis C treatment in India for less than $1000". hep-c-news.com. Hep C News. 11 July 2016. Archived from the original on 16 September 2016.

worldcat.org

search.worldcat.org

Dandekar, Vikas (28 December 2016). "Cadila Healthcare misbranded Saroglitazar, says US FDA". The Economic Times. ISSN 0013-0389. Retrieved 1 August 2023.